Gross spread

IN8bio Announces Pricing of Initial Public Offering

Retrieved on:

Friday, July 30, 2021

Finance, Financial markets, Initial public offering, Financial economics, Corporate finance, Stock market, Underwriting, Public offering, Gross spread

NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies utilizing its DeltEx platform (IN8bio or the Company), today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $40 million, before underwriting discounts and commissions and estimated offering expenses.

Key Points:

NEW YORK, July 30, 2021 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies utilizing its DeltEx platform (IN8bio or the Company), today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $40 million, before underwriting discounts and commissions and estimated offering expenses.
The offering is expected to close on August 3, 2021, subject to satisfaction of customary closing conditions.
In addition, IN8bio has granted the underwriter a 30-day option to purchase up to an additional 600,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.
A registration statement related to the shares being sold in this offering was declared effective by the Securities and Exchange Commission on July 29, 2021.

IN8bio Launches Proposed Initial Public Offering

Retrieved on:

Thursday, July 22, 2021

Initial public offering, Financial markets, Finance, Financial economics, Corporate finance, Stock market, Underwriting, Public offering, Greenshoe, Gross spread

In addition, IN8bio expects to grant the underwriter a 30-day option to purchase up to 600,000 additional shares of common stock at the public offering price, less the underwriting discount.

Key Points:

In addition, IN8bio expects to grant the underwriter a 30-day option to purchase up to 600,000 additional shares of common stock at the public offering price, less the underwriting discount.
All of the shares to be sold in the proposed offering will be offered by IN8bio.
The initial public offering price is expected to be between $10.00 and $12.00 per share.
Certain statements herein concerning the Companys future expectations, plans and prospects, including without limitation, the pricing of the Companys proposed initial public offering, may constitute forward looking statements.

Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering

Retrieved on:

Tuesday, March 23, 2021

Initial public offering, Finance, Financial markets, Financial economics, Corporate finance, Stock market, Underwriting, Public offering, Gross spread

Jian, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the Company), a pharmaceutical producer and distributor in China, today announced the pricing of its initial public offering (Offering) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share.

Key Points:

Jian, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the Company), a pharmaceutical producer and distributor in China, today announced the pricing of its initial public offering (Offering) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share.
The Company expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses.
In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts.
The Offering is expected to close on or about March 25, 2021, subject to the satisfaction of customary closing conditions.

AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of Common Stock

Retrieved on:

Friday, February 19, 2021

Finance, Financial economics, Stock market, Initial public offering, Corporate finance, Financial markets, Actuarial science, Underwriting, Public offering, Stock, eHealthInsurance, Gross spread

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announcedunderwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share.

Key Points:

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the closing of its previously announcedunderwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share.
As previously announced, the Company has granted to the underwriter a 30-day option to purchase up to 7,031,250 additional shares of common stock at the public offering price, less underwriting discounts and commissions.
The gross proceeds to the Company from the offering are $75 million, before deducting underwriting discounts and commissions and other offering expenses.
The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.

Montauk Renewables Announces Pricing of $25.9 Million Initial Public Offering

Retrieved on:

Friday, January 22, 2021

Financial markets, Finance, Financial economics, Stock market, Corporate finance, Initial public offering, Underwriting, Public offering, Offering, Gross spread

PITTSBURGH, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (the Company) announced today the pricing of its initial public offering of 3,047,015 shares at a price of $8.50 per share.

Key Points:

PITTSBURGH, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (the Company) announced today the pricing of its initial public offering of 3,047,015 shares at a price of $8.50 per share.
The offering is subject to customary closing conditions and is expected to close on January 26, 2021.
The Company has granted the underwriter a 30-day option to purchase up to an additional 352,500 shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and expectations regarding the use of proceeds of the offering.

Global Water Announces Pricing of Public Offering of Common Stock

Retrieved on:

Thursday, January 16, 2020

Financial markets, Finance, Financial economics, Initial public offering, Corporate finance, Stock market, Underwriting, Actuarial science, Public offering, NASDAQ, Stock, Gross spread

PHOENIX, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, today announced the pricing of an underwritten public offering of 870,000 shares of its common stock at a price to the public of $12.50 per share.

Key Points:

PHOENIX, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, today announced the pricing of an underwritten public offering of 870,000 shares of its common stock at a price to the public of $12.50 per share.
The gross proceeds to the company from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $10.9 million.
In addition, the company has granted the underwriter for the offering a 30-day option to purchase up to an additional 130,000 shares of its common stock at the public offering price, less underwriting discounts and commissions.
Global Water Resources, Inc. is a leading water resource management company that owns and operates 12 utility companies which provide water, wastewater, and recycled water services.